Prothena Corp PLC (PRTA)
25.12
-0.95
(-3.64%)
USD |
NASDAQ |
Mar 18, 16:00
25.12
0.00 (0.00%)
After-Hours: 20:00
Prothena Cash from Operations (TTM): -133.91M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -133.91M |
September 30, 2023 | -87.84M |
June 30, 2023 | -128.53M |
March 31, 2023 | -118.86M |
December 31, 2022 | -108.82M |
September 30, 2022 | -126.30M |
June 30, 2022 | 16.97M |
March 31, 2022 | 88.86M |
December 31, 2021 | 92.60M |
September 30, 2021 | 95.97M |
June 30, 2021 | -35.54M |
March 31, 2021 | -90.86M |
December 31, 2020 | -80.36M |
September 30, 2020 | -75.76M |
June 30, 2020 | -65.30M |
March 31, 2020 | -58.70M |
December 31, 2019 | -52.97M |
September 30, 2019 | -59.73M |
June 30, 2019 | -84.36M |
March 31, 2019 | -14.13M |
December 31, 2018 | -28.28M |
September 30, 2018 | -46.55M |
June 30, 2018 | -30.71M |
Date | Value |
---|---|
March 31, 2018 | -124.92M |
December 31, 2017 | -131.18M |
September 30, 2017 | -125.46M |
June 30, 2017 | -137.79M |
March 31, 2017 | -129.04M |
December 31, 2016 | -116.25M |
September 30, 2016 | -98.27M |
June 30, 2016 | -85.12M |
March 31, 2016 | -68.94M |
December 31, 2015 | -58.60M |
September 30, 2015 | -55.30M |
June 30, 2015 | -50.65M |
March 31, 2015 | -33.30M |
December 31, 2014 | -0.683M |
September 30, 2014 | 2.004M |
June 30, 2014 | 3.965M |
March 31, 2014 | -9.101M |
December 31, 2013 | -32.10M |
September 30, 2013 | -37.90M |
June 30, 2013 | -35.04M |
March 31, 2013 | -38.55M |
December 31, 2012 | -42.07M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-133.91M
Minimum
Dec 2023
95.97M
Maximum
Sep 2021
-51.38M
Average
-70.53M
Median
Cash from Operations (TTM) Benchmarks
Amarin Corp PLC | 6.88M |
Jazz Pharmaceuticals PLC | 1.092B |
Iterum Therapeutics PLC | -30.75M |
GH Research PLC | -33.34M |
Mural Oncology PLC | -- |